Covid Vaccination Phase 2
- All
- News
- Videos
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Panel Recommends Nod To Serum Institute For Covid Jab Trials On Children
An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, sources said
-
BJP's New Plan To Shake Off COVID-19 Criticism
The BJP is set to start the second phase of a countrywide voluntary service to promote Covid vaccination, promote awareness and help people affected with the disease.
-
Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared
Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.
-
5 States, Union Territories Have No Private Facility For Covid Vaccine: Government Data
With the 3rd phase of COVID-19 vaccination opening in less than 2 weeks for everyone above 18, largely via private facilities, data shows almost all small states and union territories are still entirely or mostly dependent on government facilities.
-
Over 1 Million Registrations On CoWin For Phase 2 Vaccinations: 10 Points
Over a million people had registered on the government's CoWin portal by 1 pm today to get vaccinated against the coronavirus in the second phase of the country's inoculation drive. While the first phase of the vaccination campaign targeted healthcare and other frontline workers, the second phase that began today aims to inoculate those above 60 ye...
-
Odisha, Bihar Chief Ministers Take Vaccine Shots As India Begins Phase 2
Chief Ministers of Odisha and Bihar were among the beneficiaries as the second phase of the nationwide Covid vaccination began with Prime Minister Narendra Modi as the first beneficiary.
-
PM-CARES Fund To Cover Over 80% Cost Of 1st Phase Of Covid Vaccination: Top Official
The PM-CARES fund, which has been set up to provide relief during the coronavirus pandemic, has contributed over Rs 2,200 crore for the first phase of vaccination drive, which is looking to inoculate frontline healthcare workers, the Expenditure Secretary said on Tuesday.
-
PM Modi, Chief Ministers To Receive Shots In Round 2 Of Vaccination: Sources
Prime Minister Narendra Modi will be vaccinated in the second phase of the Covid inoculation drive launched last week, sources said today. All Chief Ministers, MPs and MLAs above 50 will also receive vaccines.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India
Dr Reddy's Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.
-
Russia Covid Vaccine May Reach Kanpur Next Week For Phase-2 Trial: Report
The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
"Will Centre Have 80,000 Crore For Covid Vaccines" Adar Poonawalla Asks
Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter to highlight potential challenges ahead of vaccine production and distribution
-
Bharat Biotech's 1st Nasal Covid Vaccine Gets Phase 2/3 Trial Nod
BBV154, developed by Bharat Biotech, is India's first intranasal vaccine to receive regulatory nod for late-stage clinical trials from the Biotechnology Industry Research Assistance Council's (BIRAC) under the Department of Biotechnology.
-
Panel Recommends Nod To Serum Institute For Covid Jab Trials On Children
An expert panel of the Central Drugs Standard Control Organisation today recommended granting permission to Serum Institute of India (SII) for conducting phase 2/3 trials of Covovax on children aged 2 to 17 years with certain conditions, sources said
-
BJP's New Plan To Shake Off COVID-19 Criticism
The BJP is set to start the second phase of a countrywide voluntary service to promote Covid vaccination, promote awareness and help people affected with the disease.
-
Covaxin Phase 2, 3 Clinical Trials For 2-18 Age Group Cleared
Covaxin trials on children from two to 18 years were cleared by the Drugs Controller General of India (DCGI) today. This is the first time in India that a Covid vaccine will be tested on children.
-
5 States, Union Territories Have No Private Facility For Covid Vaccine: Government Data
With the 3rd phase of COVID-19 vaccination opening in less than 2 weeks for everyone above 18, largely via private facilities, data shows almost all small states and union territories are still entirely or mostly dependent on government facilities.
-
Over 1 Million Registrations On CoWin For Phase 2 Vaccinations: 10 Points
Over a million people had registered on the government's CoWin portal by 1 pm today to get vaccinated against the coronavirus in the second phase of the country's inoculation drive. While the first phase of the vaccination campaign targeted healthcare and other frontline workers, the second phase that began today aims to inoculate those above 60 ye...
-
Odisha, Bihar Chief Ministers Take Vaccine Shots As India Begins Phase 2
Chief Ministers of Odisha and Bihar were among the beneficiaries as the second phase of the nationwide Covid vaccination began with Prime Minister Narendra Modi as the first beneficiary.
-
PM-CARES Fund To Cover Over 80% Cost Of 1st Phase Of Covid Vaccination: Top Official
The PM-CARES fund, which has been set up to provide relief during the coronavirus pandemic, has contributed over Rs 2,200 crore for the first phase of vaccination drive, which is looking to inoculate frontline healthcare workers, the Expenditure Secretary said on Tuesday.
-
PM Modi, Chief Ministers To Receive Shots In Round 2 Of Vaccination: Sources
Prime Minister Narendra Modi will be vaccinated in the second phase of the Covid inoculation drive launched last week, sources said today. All Chief Ministers, MPs and MLAs above 50 will also receive vaccines.
-
Gennova Biopharmaceuticals Gets Conditional Nod For Human Trial Of Its Covid Vaccine
The Drugs Controller General of India (DCGI) on Wednesday granted conditional permission for phases 1 and 2 human clinical trial of the COVID-19 vaccine candidate developed by the Pune-based Gennova Biopharmaceuticals Ltd in collaboration with HDT, USA, officials said.
-
Dr Reddy's, Russian Firm RDIF Begin Clinical Trials For Covid Vaccine Sputnik V In India
Dr Reddy's Laboratories and the Russian Direct Investment Fund (RDIF) on Tuesday announced the start of adaptive phase 2/3 clinical trials for COVID-19 vaccine Sputnik V in India after receiving necessary clearance from the Central Drugs Laboratory in Himachal Pradesh.
-
Russia Covid Vaccine May Reach Kanpur Next Week For Phase-2 Trial: Report
The first batch of Russia's Sputnik V vaccine for COVID-19 is likely to reach Kanpur's Ganesh Shankar Vidyarthi Medical College by next week wherein the vaccine's Phase 2 and Phase 3 human clinical trials will be conducted.
-
Dr Reddy's Reapplies For Clinical Trials Of Russian Covid Vaccine: Report
The Hyderabad-based Dr Reddy's Laboratories has reapplied to the Drugs Controller General of India (DCGI) seeking permission to conduct combined phases 2 and 3 human clinical trials of the Russian COVID-19 vaccine Sputnik V in India.
-
Bharat Biotech Told To Submit Phase 2 Data Of Its Covid Vaccine Before Starting Phase 3: Report
Bharat Biotech, which had sought Drugs Controller General of India or DCGI's nod for conducting phase-3 clinical trials of its COVID-19 vaccine candidate, has been asked to first submit complete safety and immunogenicity data of the ongoing phase-2 trial, besides providing some clarifications, before proceeding for the next stage.
-
"Will Centre Have 80,000 Crore For Covid Vaccines" Adar Poonawalla Asks
Adar Poonawalla, the CEO of the Serum Institute of India - the world's largest manufacturer of vaccines by volume and which is conducting Covid vaccine trials ahead of mass production - took to Twitter to highlight potential challenges ahead of vaccine production and distribution
